| 000 | 01805 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517041440.0 | ||
| 264 | 0 | _c20160429 | |
| 008 | 201604s 0 0 eng d | ||
| 022 | _a1949-2553 | ||
| 024 | 7 |
_a10.18632/oncotarget.4389 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMosrati, Mohamed Ali | |
| 245 | 0 | 0 |
_aTERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma. _h[electronic resource] |
| 260 |
_bOncotarget _cJun 2015 |
||
| 300 |
_a16663-73 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBinding Sites _xgenetics |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlioblastoma _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-1beta _xgenetics |
| 650 | 0 | 4 |
_aInterleukin-6 _xgenetics |
| 650 | 0 | 4 |
_aIsocitrate Dehydrogenase _xgenetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPolymorphism, Single Nucleotide _xgenetics |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aPromoter Regions, Genetic _xgenetics |
| 650 | 0 | 4 |
_aRNA, Messenger _xbiosynthesis |
| 650 | 0 | 4 | _aShelterin Complex |
| 650 | 0 | 4 |
_aTelomerase _xgenetics |
| 650 | 0 | 4 |
_aTelomere-Binding Proteins _xgenetics |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xgenetics |
| 700 | 1 | _aMalmström, Annika | |
| 700 | 1 | _aLysiak, Malgorzata | |
| 700 | 1 | _aKrysztofiak, Adam | |
| 700 | 1 | _aHallbeck, Martin | |
| 700 | 1 | _aMilos, Peter | |
| 700 | 1 | _aHallbeck, Anna-Lotta | |
| 700 | 1 | _aBratthäll, Charlotte | |
| 700 | 1 | _aStrandéus, Michael | |
| 700 | 1 | _aStenmark-Askmalm, Marie | |
| 700 | 1 | _aSöderkvist, Peter | |
| 773 | 0 |
_tOncotarget _gvol. 6 _gno. 18 _gp. 16663-73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.4389 _zAvailable from publisher's website |
| 999 |
_c25045800 _d25045800 |
||